Form 8-K · Current report
Moderna 8-K, filed Sep 30, 2026
- Filed
- CIK
- 0001682852
- Accession no.
- 0001193125-26-408289
Summary
Moderna appointed Juan Andres as its first Chief Operating Officer, effective October 5, 2026, reporting to CEO Stéphane Bancel and serving on the Executive Committee, and said Chief Technical Operations and Quality Officer Jerh Collins will retire. The newly created role supports the company's expansion into oncology, where it is preparing for a potential launch and scale-up of intismeran autogene, the mRNA cancer therapy it co-develops with Merck, following positive Phase 3 results.
Key points
- Andres will receive an initial annual base salary of $800,000, an annual bonus target of 90% of base salary, and a $5 million new-hire equity award vesting over four years, with a future annual equity award target of $4 million to $5 million.
- Andres previously spent nearly six years at Moderna, serving as Chief Technical Operations and Quality Officer from 2018 to 2022 and later as President, Strategic Partnerships and Enterprise Expansion before retiring in 2023.
- Collins joined Moderna in October 2022, became Chief Technical Operations and Quality Officer in January 2023, and previously spent nearly 30 years at Novartis.
- Moderna said its infectious disease franchise now includes five approved vaccines following U.S. FDA approval of its seasonal flu vaccine and European Commission marketing authorization of its seasonal flu plus COVID combination vaccine.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) and (c) On September 30, 2026, Moderna, Inc. (“Moderna” or the “Company”) announced the appointment of Juan Andres as its Chief Operating Officer (“COO”) effective October 5, 2026. In this newly created role, Mr. Andres will support the increasing scale and diversification of the Company and will report to Chief Executive Officer Stephane Bancel and serve on the Company’s Executive Committee. Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.